4164

CHC Healthcare GroupTWSE:4164 Stock Report

Market Cap

NT$5.5b

7D

2.8%

1Y

-13.2%

Updated

16 Sep, 2021

Data

Company Financials +
4164 fundamental analysis
Snowflake Score
Valuation4/6
Future Growth0/6
Past Performance3/6
Financial Health4/6
Dividends3/6

4164 Overview

CHC Healthcare Group, through its subsidiaries, engages in the distribution, repair and maintenance, and lease of the medical equipment and related parts, consumables, and medicines in Taiwan, China, and internationally.

Share Price & News

How has CHC Healthcare Group's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: 4164 is less volatile than 75% of TW stocks over the past 3 months, typically moving +/- 3% a week.

Volatility Over Time: 4164's weekly volatility (3%) has been stable over the past year.


Market Performance


7 Day Return

2.8%

4164

0.02%

TW Healthcare

0.2%

TW Market


1 Year Return

-13.2%

4164

-3.2%

TW Healthcare

34.2%

TW Market

Return vs Industry: 4164 underperformed the TW Healthcare industry which returned -3.2% over the past year.

Return vs Market: 4164 underperformed the TW Market which returned 34.2% over the past year.


Shareholder returns

4164IndustryMarket
7 Day2.8%0.02%0.2%
30 Day6.0%0.1%4.2%
90 Day-5.4%-7.6%0.2%
1 Year-8.2%-13.2%0.005%-3.2%38.1%34.2%
3 Year10.9%-3.4%55.3%38.9%78.2%59.9%
5 Year-7.8%-24.3%91.1%58.3%122.9%85.5%

Long-Term Price Volatility Vs. Market

How volatile is CHC Healthcare Group's share price compared to the market and industry in the last 5 years?


Simply Wall St News

CHC Healthcare Group Fundamentals Summary

How do CHC Healthcare Group's earnings and revenue compare to its market cap?
4164 fundamental statistics
Market CapNT$5.51b
Earnings (TTM)NT$383.20m
Revenue (TTM)NT$2.45b

14.4x

P/E Ratio

2.2x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
4164 income statement (TTM)
RevenueNT$2.45b
Cost of RevenueNT$1.62b
Gross ProfitNT$826.43m
ExpensesNT$443.24m
EarningsNT$383.20m

Last Reported Earnings

Jun 30, 2021

Next Earnings Date

n/a

Earnings per share (EPS)2.51
Gross Margin33.72%
Net Profit Margin15.63%
Debt/Equity Ratio72.5%

How did 4164 perform over the long term?

See historical performance and comparison

Dividends

5.7%

Current Dividend Yield

80%

Payout Ratio

Valuation

Is CHC Healthcare Group undervalued compared to its fair value and its price relative to the market?

18.2%

Undervalued compared to fair value


Share Price vs. Fair Value

Below Fair Value: 4164 (NT$35.25) is trading below our estimate of fair value (NT$43.1)

Significantly Below Fair Value: 4164 is trading below fair value, but not by a significant amount.


Price To Earnings Ratio

PE vs Industry: 4164 is good value based on its PE Ratio (14.4x) compared to the TW Healthcare industry average (18.2x).

PE vs Market: 4164 is good value based on its PE Ratio (14.4x) compared to the TW market (16.4x).


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate 4164's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: 4164 is good value based on its PB Ratio (0.9x) compared to the TW Healthcare industry average (1.8x).


Future Growth

How is CHC Healthcare Group forecast to perform in the next 1 to 3 years based on estimates from 1 analyst?

19.7%

Forecasted Healthcare industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as CHC Healthcare Group has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Past Performance

How has CHC Healthcare Group performed over the past 5 years?

26.4%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: 4164 has high quality earnings.

Growing Profit Margin: 4164's current net profit margins (15.6%) are higher than last year (14.3%).


Past Earnings Growth Analysis

Earnings Trend: 4164's earnings have grown significantly by 26.4% per year over the past 5 years.

Accelerating Growth: 4164's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: 4164 had negative earnings growth (-2.5%) over the past year, making it difficult to compare to the Healthcare industry average (-2.8%).


Return on Equity

High ROE: 4164's Return on Equity (6.2%) is considered low.


Financial Health

How is CHC Healthcare Group's financial position?


Financial Position Analysis

Short Term Liabilities: 4164's short term assets (NT$3.6B) exceed its short term liabilities (NT$1.1B).

Long Term Liabilities: 4164's short term assets (NT$3.6B) do not cover its long term liabilities (NT$4.5B).


Debt to Equity History and Analysis

Debt Level: 4164's debt to equity ratio (72.5%) is considered high.

Reducing Debt: 4164's debt to equity ratio has reduced from 77.3% to 72.5% over the past 5 years.

Debt Coverage: 4164's debt is well covered by operating cash flow (20.5%).

Interest Coverage: 4164's interest payments on its debt are well covered by EBIT (10.9x coverage).


Balance Sheet


Dividend

What is CHC Healthcare Group current dividend yield, its reliability and sustainability?

5.69%

Current Dividend Yield


Dividend Yield vs Market

Notable Dividend: 4164's dividend (5.69%) is higher than the bottom 25% of dividend payers in the TW market (1.94%).

High Dividend: 4164's dividend (5.69%) is in the top 25% of dividend payers in the TW market (5.26%)


Stability and Growth of Payments

Stable Dividend: 4164 has been paying a dividend for less than 10 years and during this time payments have been volatile.

Growing Dividend: 4164 has only been paying a dividend for 9 years, and since then payments have fallen.


Current Payout to Shareholders

Dividend Coverage: At its current payout ratio (80%), 4164's payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: Insufficient data to determine if a dividend will be paid in 3 years and that it will be covered by earnings.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

3.2yrs

Average management tenure


CEO

Pei-Lin Lee

3.17yrs

Tenure

NT$11,711,000

Compensation

Mr. Pei-Lin Lee is Legal Director Representative of Huan Rui Medical Investment Holdings Co., Ltd. Mr. Lee has been Chairman of CHC Healthcare Group since November 25, 2012 and serves as its President. Mr....


CEO Compensation Analysis

Compensation vs Market: Pei-Lin's total compensation ($USD422.87K) is above average for companies of similar size in the TW market ($USD174.39K).

Compensation vs Earnings: Pei-Lin's compensation has been consistent with company performance over the past year.


Leadership Team

Experienced Management: 4164's management team is considered experienced (3.2 years average tenure).


Board Members

Experienced Board: 4164's board of directors are considered experienced (9.7 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 11%.


Top Shareholders

Company Information

CHC Healthcare Group's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: CHC Healthcare Group
  • Ticker: 4164
  • Exchange: TWSE
  • Founded: 1977
  • Industry: Health Care Distributors
  • Sector: Healthcare
  • Market Cap: NT$5.509b
  • Shares outstanding: 156.29m
  • Website: https://www.chengyeh.com

Location

  • CHC Healthcare Group
  • No. 366, Changchun Road
  • 6th Floor
  • Taipei
  • Taiwan

Listings


Biography

CHC Healthcare Group, through its subsidiaries, engages in the distribution, repair and maintenance, and lease of the medical equipment and related parts, consumables, and medicines in Taiwan, China, and i...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/09/16 15:36
End of Day Share Price2021/09/16 00:00
Earnings2021/06/30
Annual Earnings2020/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.